Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Pharmacology stubs
Technetium (99mTc) pentetic acid
Другие языки:

    Technetium (99mTc) pentetic acid

    Подписчиков: 0, рейтинг: 0
    Technetium (99mTc) pentetic acid
    Technetium (99mTc) pentetic acid.svg
    Clinical data
    Trade names Draximage DTPA
    License data
    Routes of
    administration    		 Intravenous, inhalation
    ATC code
    Legal status
    Legal status
    Identifiers
    CAS Number
    PubChem CID
    ChemSpider
    UNII
    Chemical and physical data
    Formula C14H18N3NaO10Tc
    Molar mass 509 g·mol−1
    3D model (JSmol)
    • C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[99Tc+4]
    • InChI=1S/C14H23N3O10.Na.Tc/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);;/q;+1;+4/p-5
    • Key:VTPAYRVYYYAMJN-UHFFFAOYSA-I

    Technetium (99mTc) pentetic acid, sold under the brand name Draximage DTPA among others, is a radiopharmaceutical medication used in nuclear medicine to image the brain, kidneys, or lungs. It is given by intravenous injection or via aerosol spray. It consists of technetium-99m bound to the conjugate base of pentetic acid, with sodium as an additional cation.

    Medical uses

    Technetium (99mTc) pentetic acid is indicated for use in the diagnosis of the brain, kidneys, or lungs.



    Новое сообщение